[EN] DUAL AMYLIN AND CALCITONIN RECEPTOR AGONISTS AND USES THEREOF<br/>[FR] DOUBLES AGONISTES DU RÉCEPTEUR DE LA CALCITONINE ET DE L'AMYLINE ET LEURS UTILISATIONS
申请人:[en]ELI LILLY AND COMPANY
公开号:WO2022133187A1
公开(公告)日:2022-06-23
The present disclosure related to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity, and/or dyslipidemia. The disclosure relates to compounds that agonize both the calcitonin and amylin receptors and can lower food intake, body weight, glucose and/or triglycerides, so can be used to treat diabetes, obesity and/or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.